Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
The latest announcement is out from Pharmaxis Ltd ( (AU:SNT) ).
Syntara Limited has announced the quotation of its securities on the Australian Securities Exchange (ASX), marking a significant step in its financial operations. The company issued 186,100 ordinary fully paid securities as of January 22, 2025. This move could potentially enhance Syntara Limited’s market presence and attract investor interest, reflecting its strategic efforts to leverage market opportunities.
More about Pharmaxis Ltd
YTD Price Performance: -8.75%
Average Trading Volume: 5,078,209
Technical Sentiment Consensus Rating: Hold
Current Market Cap: A$115.3M
See more data about SNT stock on TipRanks’ Stock Analysis page.